CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 1 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $465,000 | +56.0% | 29,631 | +4.7% | 0.00% | +100.0% |
| Q3 2015 | $298,000 | -87.1% | 28,309 | -69.2% | 0.00% | -83.3% |
| Q2 2015 | $2,318,000 | -18.9% | 91,912 | -10.3% | 0.01% | -29.4% |
| Q1 2015 | $2,857,000 | -75.0% | 102,494 | -83.6% | 0.02% | -76.7% |
| Q4 2014 | $11,439,000 | +42.1% | 626,812 | +0.9% | 0.07% | +128.1% |
| Q3 2014 | $8,051,000 | +85.1% | 621,189 | +133.1% | 0.03% | +45.5% |
| Q2 2014 | $4,350,000 | – | 266,535 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KLP Enterprises, LLC | 6,865,006 | $16,957,000 | 100.00% |
| Meditor Group Ltd | 5,800,000 | $14,326,000 | 2.16% |
| TSP Capital Management Group, LLC | 1,135,748 | $2,805,000 | 1.29% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 8,526,619 | $21,061,000 | 0.30% |
| Marcus Capital, LLC | 103,800 | $256,000 | 0.22% |
| Benchmark Capital Advisors | 64,800 | $160,000 | 0.13% |
| Vident Investment Advisory, LLC | 480,018 | $1,186,000 | 0.10% |
| Bellevue Group AG | 160,000 | $395,000 | 0.05% |
| NJ State Employees Deferred Compensation Plan | 100,000 | $247,000 | 0.05% |
| Virtus ETF Advisers LLC | 126,989 | $314,000 | 0.05% |